For major depression, a decrease of interleukin (IL)-6 serum levels based on the treatment with SSRIs has been shown before [19], eliciting possible anti-inflammatory mechanisms of SSRIs besides the increase of serotonin. The gene discussed is IL6; the disease is major depressive disorder.